Advanced search
Publication Cover
Clinical Toxicology Volume 57, 2019 - Issue 2
Submit an article Journal homepage
489
Views
24
CrossRef citations to date
0
Altmetric
Clinical Research

Fetal death associated with the use of 3,4-MDPHP and α-PHP

Piotr AdamowiczDepartment of Forensic Toxicology, Institute of Forensic Research, Kraków, Poland; Correspondence[email protected]
&
Piotr HydzikDepartment of Clinical Toxicology, Jagiellonian University Medical College, Kraków, Poland
Pages 112-116 | Received 25 May 2018, Accepted 17 Jul 2018, Published online: 17 Aug 2018

References

  • European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2018: Trends and Developments. Publications Office of the European Union, Luxembourg; 2018.
  • Koeppe H, Zeile K, Ludwig G. Patent DE1545591 – Verfahren zur Herstellung von α-Aminoketonen mit heterocyclischer Aminogruppe. 1965.
  • European Monitoring Centre for Drugs and Drug Addiction. Europol 2014 Annual Report on the implementation of Council Decision 2005/387/JHA. Publications Office of the European Union, Luxembourg; 2015. http://www.emcdda.europa.eu/attachements.cfm/att_240380_EN_TDAN15001ENN.pdf.
  • https://hyperreal.info/. [Accessed 2018 May 15].
  • http://bluelight.org/. [Accessed 2018 May 15].
  • https://psychonautwiki.org/. [Accessed 2018 May 15].
  • Adamowicz P, Tokarczyk B. Simple and rapid screening procedure for 143 new psychoactive substances by liquid chromatography-tandem mass spectrometry. Drug Test Analysis. 2016;8:652–667.
  • Gray BA, Holland C. Implications of psychoactive “bath salts” use during pregnancy. Nurs Womens Health. 2014;18:220–230.
  • Pichini S, Rotolo MC, García J, et al. Neonatal withdrawal syndrome after chronic maternal consumption of 4-methylethcathinone. Forensic Sci Int. 2014;245:e33–e35.
  • Ross EJ, Graham DL, Money KM, et al. Developmental consequences of fetal exposure to drugs: what we know and what we still must learn. Neuropsychopharmacol. 2015;40:61–87.
  • Smith LM, Diaz S, LaGasse LL, et al. Developmental and behavioral consequences of prenatal methamphetamine exposure: a review of the infant development, environment, and lifestyle (IDEAL) study. Neurotoxicol. Teratol. 2015;51:35–44.
  • Rickli A, Hoener MC, Liechti ME. Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones. Eur. Neuropsychopharmacol. 2015;25:365–376.
  • Valente MJ, Amaral C, Correia-da-Silva G, et al. Methylone and MDPV activate autophagy in human dopaminergic SH-SY5Y cells: a new insight into the context of β-keto amphetamines-related neurotoxicity. Arch Toxicol. 2017;91:3663–3676.
  • Valente MJ, Bastos ML, Fernandes E, et al. Neurotoxicity of β-Keto amphetamines: deathly mechanisms elicited by methylone and MDPV in human dopaminergic SH-SY5Y cells. ACS Chem Neurosci. 2017;8:850–859.
  • Sakai K, Iwadate K, Maebashi K, et al. Infant death associated with maternal methamphetamine use during pregnancy and delivery: a case report. Leg Med (Tokyo). 2015;17:409–414.
  • Gibbons S, Zloh M. An analysis of the “legal high” mephedrone. Bioorg Med Chem Lett. 2010;20:4135–4139.
  • Simmler LD, Buser TA, Donzelli M, et al. Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol. 2013;168:458–470.
  • Campbell NG, Koprich JB, Kanaan NM, et al. MDMA administration to pregnant Sprague-Dawley rats results in its passage to the fetal compartment. Neurotoxicol Teratol. 2006;28:459–465.
  • Coppola M, Mondola R. Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as “bath salts” or “plant food.”. Toxicol Lett. 2012;211:144–149.
  • Strange LG, Kochelek K, Keasling R, et al. The pharmacokinetic profile of synthetic cathinones in a pregnancy model. Neurotoxicol Teratol. 2017;63:9–13.
  • Garite TJ. Intrapartum fetal evaluation. In: Gabbe SG, Niebyl JR, Simpson JL, Landon MB, Galan HL, Jauniaux ERM, Driscoll DA, editors. Obstetrics: normal and problem pregnancies. 6th ed. Philadelphia, PA: Saunders Elsevier; 2012.
  • Stewart JL, Meeker JE. Fetal and infant deaths associated with maternal methamphetamine abuse. J Anal Toxicol. 1997;21:515–517.
  • Kalapos MP. 3,4-methylene-dioxy-pyrovalerone (MDPV) epidemic? Orv Hetil. 2011;152:2010–2019.
  • Pedersen AJ, Reitzel LA, Johansen SS, et al. In vitro metabolism studies on mephedrone and analysis of forensic cases. Drug Test Analysis. 2013;5:430–438.
  • Peters J, Keasling R, Brown S, et al. Quantification of synthetic cathinones in rat brain using HILIC-ESI-MS/MS. J Anal Toxicol. 2016;40:718–725.
  • Adamowicz P, Gil D, Skulska A, et al. Analysis of MDPV in blood-determination and interpretation. J Anal Toxicol. 2013;37:308–312.
  • Adamowicz P, Gieroń J, Gil D, et al. Blood concentrations of α-pyrrolidinovalerophenone (α-PVP) determined in 66 forensic samples. Forensic Toxicol. 2016;34:227–234.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.